Names that wouldn’t make it past updated EMA guidance

To bring some more attention to the EMA’s updated guidance on the naming of medicines, we thought we’d share a few names that are unlikely to be acceptable…

  • Neverwerx
  • Queurit
  • Susartapine
  • Quaxx
  • Plassibeau